Scientists Identify Predictive Blood Biomarker for Cognitive Impairment, Dementia
A recent study revealed that low levels of ergothioneine in blood plasma may predict an increased risk of cognitive impairment and dementia.
Read MorePosted by Andy Lundin | Dec 20, 2022 | Dementias & Alzheimer’s |
A recent study revealed that low levels of ergothioneine in blood plasma may predict an increased risk of cognitive impairment and dementia.
Read MorePosted by Andy Lundin | Dec 19, 2022 | Covid 19 |
Ubiquitome’s next generation real-time PCR device system, the Liberty16 Pro, has been given Emergency Use Approval (EUA) by the FDA.
Read MorePosted by Andy Lundin | Dec 16, 2022 | Covid 19, Diagnostic Technologies, Flu & Respiratory Infections |
Sameday Health launched a single swab test for COVID, influenza A/B strains, and respiratory syncytial virus (RSV).
Read MorePosted by Andy Lundin | Dec 15, 2022 | Prostate |
Researchers pioneered and implemented a novel algorithm to provide genetic testing to patients with newly diagnosed prostate cancer.
Read MorePosted by Chris Wolski | Dec 15, 2022 | Covid 19 |
Roche has entered into a U.S. focused collaboration with Pfizer to drive awareness and educate on the importance of timely COVID-19 testing.
Read More